A Phase 1/2 Study of Repeated Intravenous E6011 Administration in Japanese Subjects With Crohn's Disease

Clinical trial NCT02039063 · COMPLETED

Trial details

NCT number: NCT02039063
Sponsor: EA Pharma Co., Ltd.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Crohn's Disease

Start date: 2014-04-05
Primary completion: 2017-01-06
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.